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ABSTRACT
Objective: Five methanol plant extracts namely, Euphorbia hierosolymitana, Dracaena marginata, Cordyline terminalis, and Sapium sebifera were 
screened in vitro for their cytotoxic effect on human tumor cell lines; namely, PC-3, HepG-2, HCT-116, and MCF-7 (prostate, liver, colon, and breast 
cancer) and human normal cell lines, namely, BJ-1.
Methods: E. hierosolymitana (extract A) selectively inhibited HCT-116 cell proliferation with IC50 of 4.22 µg/ml, both Dracaena marginata (extract B) 
(bark, leaves, and branches) showed moderate cytotoxicity on MCF-7 with IC50 of 22.4 and 48.2 µg/ml, respectively. The remaining two extracts 
showed minimal to insignificant percentage inhibition on all cell lines.
Results: E. hierosolymitana extract was selected for further studying, where the effect of the extract on the HCT116 cells showed a downregulation of 
her2 and Bcl-2 gene and overexpression of the Bax gene. Flow cytometry analysis was also performed to understand the effect of E. hierosolymitana 
on the apoptosis induction and the cell cycle. The results showed the induction of early and late apoptosis by 5.81 and 10.01%, respectively.
Conclusion: Our results infer that E. hierosolymitana has a promising chance in fighting colorectal cancer due to its high cytotoxic effects on HCT116 
cancer cells while having minimal effects on the BJ-1 normal cell lines.
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INTRODUCTION
The natural environment has been a source of medicinal agents for 
thousands of years and is still being used for treating various types of 
diseases. At present, there are a remarkable number of drugs that have 
been isolated from natural plant species. Euphorbia hierosolymitana 
(extract A) is a member of the Euphorbiaceae (spurge) family. 
Euphorbiaceae family members have been used in alternative medicine 
for skin disorders, diarrhea, dysentery, and venereal diseases [1].
Dracaena marginata is a species of the Dracaena genus which is 
commonly used as ornamental and medicinal plants. Extract D and 
extract E are Dracaena Marginata (bark) and Dracaena Marginata (leaf 
and branch) respectively. Plants like D. marginata alongside with other 
Dracaena species are effective in decreasing the concentration of the 
volatile organic compound in the air [2]. Cordyline fruticosa (extract C) is 
commonly known as Hawaiian Ti plant. It is an arborescent (tree-like 
structure) monocotyledon which is classified into the Agavaceae family. 
The leaves were reported to contain tyramine, it is predicted to cause an 
increase in the systolic blood pressure if ingested in high amounts [3].
Sapium sebifera (extract B) which is also known as Triadica sebifera and 
commonly known as the Chinese tallow tree is a native plant of South 
and Central China with high fertility. It is a member of the Euphorbiaceae 
family, which is a complex heterogeneous family with around 322 
genera and 8900 species [4]. Cancer is characterized by out-of-control 
cell growth with the potential to invade or spread to other parts of 
the body. Apoptosis is controlled by a very complex, energy-requiring 
series of events. There are three main apoptotic pathways: Extrinsic 
or death receptor pathway, intrinsic or mitochondrial pathway, and 
T-cell-mediated cytotoxicity which involves perforin-granzyme-
dependent killing [5].
Bcl-2 has been shown to have anti-apoptotic effects by blocking the 
release of cytochrome c while, in turn, reduce the activity of caspase-9, 
while Bax (Bcl-2-associated X protein) is a pro-apoptotic protein that 
belongs to the Bcl-2 family. The overexpression of the Bax results in the 
promotion of cell death, in other words, the balance between the Bcl-2 
and Bax determines the cell fate. However, the mechanism of the Bax is 
not always related to Bcl-2. Cells, where the Bax gene was knocked out, 
were still susceptible to apoptosis. However, cells with double-knockout 
Bax−/−/Bak−/− were almost resistant to all apoptotic stimuli [6].
METHODS
All the plants were randomly collected from different regions of Egypt. 
The plant samples, herbs from Euphorbia hierosolymitana (extract A) 
branches of Sapium sebifera (extract B) leaves and branches of Cordyline 
fruticosa (extract C); bark of Dracaena marginata and leaves and 
branches of Dracaena marginata (extracts D and E), were dried in solar 
ovens at 40°C then ground into powder. The powder was thoroughly 
extracted with 95% methanol. The extracts were then freeze-dried and 
stored at −20°C until needed [7].
Cancer cell lines
In this study, we used human breast adenocarcinoma cell line (MCF-7), 
the hepatocellular carcinoma cell line (HepG-2), the human colon 
carcinoma cell line (HCT-116), the human prostate adenocarcinoma cell 
line (PC-3), and a normal human cell line (BJ-1).
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2020.v13i10.38698
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These cell lines were obtained from Karolinska Institute, Department of 
Oncology and Pathology (Stockholm, Sweden).
Cell preparation
MCF-7, HCT116, PC3, and BJ1 cells were maintained in DMEM medium 
(Dulbecco’s Modified Eagle’s Medium, Lonza, Basel, Switzerland). 
While RPMI medium (in case of HepG2) (Gibco, Gergy Pouloisa, 
France) was used instead of the DMEM and supplemented with 10% 
fetal bovine serum at 37oC in 5% CO2 and 95% humidity, cells were 
subcultured using Trypsin-Versene 0.15%. Skin normal human cell 
line (BJ-1) immortalized normal foreskin fibroblast cell line was kindly 
provided by Professor Stig Linder, Oncology and Pathology department, 
Karolinska Institute, Stockholm, Sweden.
MTT assay
The antiproliferative effects of the plant extracts were tested in vitro on 
the five cell lines, MCF-7, HepG-2, HCT-116, PC-3, and BJ-1, using the 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
assay [8]. The cells were cultured in 96-well plates, where each well 
contains 1×105 cells. A 100 ppm final concentration of the extracts was 
added in triplicates. The cells were incubated for 48 h. Doxorubicin was 
used as positive control and 0.5% DMSO was used as a negative control. 
Cytotoxicity was determined using MTT [3-(4, 5-dimethythiazol-2-
yl)-2, 5-diphenyltetrazolium bromide] assay, as described by Mosmann, 
1983 [9].
The media were discarded and 40 µl of MTT (Bio Basic, New York, 
USA) was added then the plates were incubated for 3–4 h in 5% CO2 
incubator. After the incubation, 140 µl of 1% sodium dodecyl sulfate 
(SDS) (solubilizing reagent) (ADWIC, Egypt) was added to each well 
and left for 20 min. The color formed was then measured at 595 nm, on 
a microplate reader [10]. Using different concentrations ranging from 
100, 50, 25, 12.5, 6.25, and 3.125 ppm [11], the IC50 was calculated using 
the software program SPSS (Statistical analysis software package, v9, 
Chicago, USA).
Percentage inhibition= 100 – (abs. of treated cells/abs. of untreated 
cells) × 100.
RNA isolation
The effect of the plant extract A (Euphorbia hierosolymitana) on the 
mRNA expression of the Bcl-2, ERBB2/her2, and Bax was determined 
by a reverse transcription-polymerase chain reaction (RT-PCR) 
technique. After the treatment (48 h) [12] of the HCT116 cells with the 
extract, RNA was extracted from the cells using the RNeasy extraction 
kit (Qiagen, Hilden, Germany) following the manufacturer’s protocol. 
Concisely, up to 1 × 106 of the cultured cells were trypsinized, washed 
with PBS, and collected in an RNase-free centrifuge tube. The sample 
was then centrifuged at 300 ×g for 5 min, and the supernatant was 
aspirated off. The pellet was disrupted and homogenized in RLT 
buffer (buffer RLT is a lysis buffer for lysing cells and tissues before 
RNA isolation and simultaneous RNA/DNA/protein isolation).
The homogenized lysate was then transferred into a 2 ml collection 
tube, and 1 ml of 70% ethanol was added to the lysate and mixed 
with pipetting. Then, 700 µl of the sample was transferred into an 
RNeasy spin column placed in a 2 ml collection tube and centrifuged at 
10,000 rpm for 15 sec. The flow-through was discarded, and 700 µl of 
the RW1 buffer (buffer RW1 is a proprietary component of RNeasy kits. 
Buffer RW1 contains a guanidine salt, as well as ethanol, and is used as a 
stringent washing buffer that efficiently removes biomolecules such as 
carbohydrates, proteins, and fatty acids) was added to the spin column 
and centrifuged at 10,000 rpm for 15 s.
The previous step was repeated 2 times using 500 µl of the RPE 
buffer (buffer RPE is a mild washing buffer and a proprietary 
component of RNeasy kits. Its main function is to remove traces of 
salts, which are still on the column due to buffers used earlier in 
the protocol) instead of the RW1 buffer to wash the spin column 
membrane. The collection tube was discarded, and a new 1.5 ml 
tube was used instead, 40 µl of RNase-free water was added to the 
center of the membrane and centrifuged at 10,000 rpm for 1 min. 
The spin column was discarded as the collection tube contains the 
eluted RNA.
Gene expression analysis
After the RNA extraction, one-step RT-qPCR was performed using 
iScript™ One-Step RT-PCR kit with SYBR® Green (Bio-Rad Inc., CA, USA) 
which was added to the Master Mix which contained 25 µl 2x SYBR 
Green®, 1.5 µl forward primer (10 µM), 1.5 µl reverse primer (10 µM), 
11 µl nuclease-free water, and 1 µl ×50 iScript Reverse Transcriptase 
in a final reaction volume of 50 µl. Two control reactions were created; 
one lacking the RNA template and the other lacking the reverse 
transcriptase enzyme.
The one-step RT-qPCR reaction included an incubation step with 
the complete reaction mix, iScript Reverse Transcriptase enzyme 
inactivation step, qPCR step (denaturation, annealing, and extension), 
and dissociation step. The amplification reactions were carried out using 
the Rotor-Gene Q Real-Time PCR system (Qiagen, Hilden, Germany).
The primers’ sequences used to quantify the gene expression of the of 
Her2 are
F: 5’-ATC TGC CTG ACA TCC ACG-3’and R: 5’-GCA ATC TGC ATA CAC CAG 
TTC-3’.
Bax gene is F: 5’-GTT TCA TCC AGG ATC GAG CAG-3’and R: 5’-CAT CTT 
CTT CCA GAT GGT GA-3’.
β-Actin gene is F: 5’-TTC CTG GGC ATG GAG TC-3’ and R: 5’-CAG GTC TTT 
GCG GAT GTC-3’.
Bcl-2 gene is F: 5’-TTGTGGCCTTCTTTGAGTTCGGTG–3’ and
R: 5’GGTGCCGGTTCAGGTACTCAGTCA-3’.
Flow cytometry
For the measurement of the cellular DNA content, flow cytometric 
analysis was carried out using the Annexin V-FITC Apoptosis Detection 
Fig. 1: Schematic representation of the mean cytotoxicity induced by methanol plant extracts on the MCF-7, HEGP2, HCT116, PC3, and BJ1 
cells. Four of the five extracts, B, C, D, and E, were tested using four concentrations 100, 50, 25, and 12.5 ppm. and the last extract, A, was 
tested using eight concentrations 100, 50, 25, 12.5, 6.25, 3.125, 1.56, and 0.78 ppm on HCTT-116 as it had significant inhibitory effects
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kit (BioVision, CA, USA). After 48 h of treatment, HCT116 cells were 
trypsinized and washed with serum-containing media. The solution was 
then centrifuged at 300×g for 10 min, the supernatant was decanted, 
and the pellet was resuspended in 500 µl of ×1 binding buffer. Then, 
5 µl of Annexin V-FITC and 5 µl of propidium iodide were incubated 
with the cells for 5 min in the dark. The sample was quantified by BD 
FACSCalibur (BD Bioscience, CA, USA) [8].
RESULTS
Cytotoxicity assay
Data were pooled from the MTT assays where five methanol plant 
extracts were tested on five human cancer cell lines. The mean 
percentage inhibition and the IC50 of the extracts on each cell line are 
represented below. Probit analysis was performed using the SPSS 
software program.
All tested extracts did not have any cytotoxic effects on the HepG-2 or 
PC-3 cell line.
Extracts D and E showed relatively high percentage inhibition 
(87.29% and 86.13%) and (81.78% and 74.35%), respectively, on 
the MCF-7 cells when used in high concentrations (100 and 50 ppm) 
while having minimal to moderate effects (72.06% and 23.80%) and 
(15.5% and 4.82%), respectively, when used in low concentrations 
(25 and 12.5 ppm). IC50 and IC90 values of extracts D on the MCF-7 
cell line were 22.4 and 84.7 while IC50 and IC90 values of extracts E 
were 48.2 and 92.4 ppm. Three of the tested extracts, B, C, and D, 
did not show any significant inhibitory effects on the HCT-116 cells. 
Whereas, extract E showed moderate inhibitory effects on the cells 
at concentrations of 100 and 50 ppm. On the other hand, A showed 
very high cytotoxicity on the cells at 12.5 ppm concentration, so 
it was further tested with concentrations of 6.25, 3.125, 1.56, and 
0.78 ppm.
The IC50 and IC90 were calculated for extracts A and E. The values of IC50 
and IC90 for extract A were 4.22 and 17.6 ppm, respectively, while the 
values for extract E were 62.04 and 17.9 ppm.
According to the National Cancer Institute Guidelines, extracts with 
IC50 values <20 µg/ml are considered active. Thus, the Euphorbia 
hierosolymitana (extract A), which has an IC50 of 4.22 µg/ml in HCT116 
cell line, showed minimal to insignificant effects on the BJ1 cells with 
5.57 and 0%; mean inhibition at 25 and12.5 ppm, respectively, was 
selected for further in vitro testing which is discussed (Table 1 and 
Fig. 1).
Gene expression quantitation
The effects of IC50 (4.22 ppm for HCT116) using methanol extract of 
Euphorbia hierosolymitana on the gene regulation was investigated by 
qRT-PCR by measuring the level of expression of her2, Bax, and Bcl-2 
genes in HCT-116 cells. Gene expression changes are represented as 
fold changes and were calculated using 2- Ct method 
 Ct = 2Ct (treated cells)-Ct (control cells) (2)
DMSO and the β-actin gene were used as internal control; as it is a 
highly conserved gene that is commonly used as an internal control for 
gene expression analysis [13].
After comparing the Her2, Bax, and Bcl-2 gene expression levels of the 
treated and untreated cells, there was a very slight down expression in 
the her2 gene by 0.09 folds, overexpression in the Bax gene by 14.37 
folds, and almost no change in the expression of Bcl-2 gene by 0.95 folds 
(Fig. 2).
Apoptosis induced by Euphorbia hierosolymitana
The typical morphological features of apoptosis are disruption of 
the cell membrane permeability, cellular shrinkage, and nuclear 
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characterized by cellular DNA staining with PI and observed using flow 
cytometry. After the HCT116 cells were treated with extract A, there 
was a decrease in the proportion of the cells in the G0-G1 phase and 
the S phase, and an increase in the G2/M phase and the pre-G1 phase 
(Table 2).
The apoptosis marker, phosphatidylserine (PS), is exposed to the 
surface of the plasma membrane when the cell enters apoptosis. 
This marker is detected by Annexin V, which is a Ca2+-dependent 
phospholipid-binding protein that has an affinity to PS, to investigate 
the apoptotic capacity of extract A in HCT116 cells. Flow cytometry 
revealed that the extract induced early and late apoptosis by 5.81% and 
10.01%, respectively (Table 3 and Fig. 3).
DISCUSSION
In this study, different plants were screened to find whether they have 
anticancer activity on multiple human cancer cell lines. Three of the five 
examined extracts showed some anti-proliferative activity. The extract 
with the most promising inhibitory effect was selected for further tests 
to recognize the mechanism of these effects.
The extracts D and E demonstrated moderate anticancer effects on 
some of the cancer cell lines.
Extract A showed high cytotoxicity on the HCT-116 cell line (IC50 of 
4.22 ppm) while having minimal effects on the normal BJ-1 cells. 
This indicates that extract A has selective toxicity for cancer cells 
specifically colon cells. However, it is still unknown if the extract will 
also affect normal colon cells. Interestingly, despite that previous 
experiments [4,14] showed that E. hierosolymitana exhibited very high 
cytotoxicity in HepG-2 cells (99.87%), the extract did not show any anti-
proliferative effects on the HepG2 cells. No previous data were found on 
the effects of E. hierosolymitana extract in HCT-116 cells [4].
Although some extracts were said to have compounds that induce high 
anticancer activity, they showed inactive or marginal effects on some of 
the cell lines. Whereas, extracts B and C were inactive in all cancer cell 
lines.
Fig. 2: Schematic representation of the gene expression profile 
for the Her2, Bcl-2, and Bax genes. The gene expression levels 
were compared with normal/untreated cells at the same 
conditions 
Fig. 3: Schematic representation of the apoptotic activity of extract A on the HCT116 cell lines. I represents the cell count in stages of the 
cell cycle (untreated control); II represents the cell count in stages of the cell cycle (treated with 4 µg/ml of extract A for 48 h); III Annexin 
V/PI (untreated control); Annexin V/PI (treated with 4 µg/ml of extract A for 48 h







% G0/G1 % S % G2/M % Pre-G1
Treated 4.22 34.41 20.4 45.19 17.39
Control  65.13 30.53 4.52 0.77
Table 3: Apoptotic effects of extract A on the HCT116 cells
Sample data Apoptosis Necrosis (%)
Total (%) Early (%) Late (%)
Treated 17.39 5.81 10.01 1.57
Control 0.77 0.14 0.22 0.41
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It was demonstrated that extract A possesses antiproliferative activity 
and induces apoptosis of HCT-116 cells. The cell cycle analysis 
showed that extract A affected the distribution of the cells in the cell 
cycle. The proportion of the cells in the G0-G1 phase and the S phase 
decreased, while it increased in the G2/M phase and the pre-G1 phase. 
These data suggest a perturbation of the cell cycle, arresting the cell 
at the G2/M phase. There was no previous cell cycle analysis made 
on E. hierosolymitana. However, Kwan et al. [8] stated that Euphorbia 
hirta, a plant from a different Euphorbia species, induced apoptosis, and 
resulted in DNA fragmentation in MCF-7 cells.
Another study on the Euphorbia dendroides L. presented that the herbs 
of the plant induced tumor apoptosis both in 2-D and 3-D of HCT-116 
and hTERT-RPE1 cultured cells [5].
Based on the flow cytometry results (Table 3), extract A induced 
5.81% in early apoptosis and 10.01% in late apoptosis. Furthermore, it 
induced necrosis with 1.57% compared to 0.41% of the untreated cells. 
E. hierosolymitana extract exhibited high apoptosis-inducing ability 
while maintaining a low necrosis induction. Therefore, the extract is 
considered promising for a potential anticancer drug.
It was demonstrated that the treatment of HCT-116 cells with extract A 
resulted in a change in the balance of Bcl-2/Bax RNA expression level 
[12], indicating that the extract can shift the anti-apoptotic/pro-apoptotic 
balance of the cells toward undergoing apoptosis (Table 3). This indicates 
that an increase in the balance between Bax/Bcl-2 is another mechanism 
of apoptosis in HCT-116 cells induced by extract A. her2/EBB2 gene is 
a member of the human epidermal growth factor receptor family [15].
The overexpression of this gene plays a significant role in the 
development and progression of a more aggressive form of cancer like 
in breast cancer. Several studies evaluated the her2 expression profile 
in colorectal cancer, and the overexpression rates varied widely from 0 
to 84% [16]. Thus, extract A was used in the treatment of HCT-116 cells 
and the her2 gene expression was quantified (Table 3).
The results showed a downregulation of the her2 gene by 0.09 folds. The 
downregulation of her2 gene often results in the induction of apoptosis 
in human cancer cells [12]. No previous her2 expression analysis 
related to E. hierosolymitana was found. Based on the gene expression 
results, E. hierosolymitana extract showed the high capability of 
inducing apoptosis by downregulating her2 genes and stimulating the 
overexpression of pro-apoptotic proteins like Bax, making this plant a 
promising anticancer drug.
CONCLUSION
The effects of Euphorbia hierosolymitana on cell proliferation and 
apoptosis could include different mechanisms, and it was demonstrated 
that extract A changed the cell cycle and affected the gene expression 
of the her2, Bax, and Bcl-2. However, the molecular mechanism that 
regulates the equilibrium between cellular proliferation and apoptosis 
requires further investigations. Due to the capacity of E. hierosolymitana 
to induce high cytotoxicity in vitro in the colon cancer cell line, It 
should be further. It should be further studied phytochemically and 
pharmacologically to isolate and identify active compounds responsible 
for the anticancer activity. Other extracts from Dracaena marginata 
plant showed moderate cytotoxic effects on one or more cancer cell 
lines and should be considered for future studies.
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